Triple

T22458011
Position Surface form Disambiguated ID Type / Status
Subject ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals E555162 entity
Predicate endorsedBy P18857 FINISHED
Object Pharmaceuticals and Medical Devices Agency Japan — NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Pharmaceuticals and Medical Devices Agency Japan | Statement: [ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals, endorsedBy, Pharmaceuticals and Medical Devices Agency Japan]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Pharmaceuticals and Medical Devices Agency Japan
Context triple: [ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals, endorsedBy, Pharmaceuticals and Medical Devices Agency Japan]
  • A. Pharmaceuticals and Medical Devices Agency Japan chosen
    The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority responsible for the review, approval, and safety monitoring of pharmaceuticals and medical devices.
  • B. Japan Pharmaceutical Manufacturers Association
    The Japan Pharmaceutical Manufacturers Association is a major industry organization representing research-based pharmaceutical companies in Japan and contributing to international regulatory harmonization and policy development.
  • C. Japan Agency for Medical Research and Development
    The Japan Agency for Medical Research and Development is a Japanese government-funded organization that coordinates and promotes medical research and innovation, from basic science through clinical application, to improve public health and foster the medical industry.
  • D. Japanese Ministry of Health and Welfare
    The Japanese Ministry of Health and Welfare was a former government ministry of Japan responsible for national public health policy, medical services, and social welfare programs before its functions were merged into the Ministry of Health, Labour and Welfare.
  • E. Science and Technology Agency of Japan
    The Science and Technology Agency of Japan was a former Japanese government body responsible for planning and coordinating national science and technology policy and research programs.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e51fdec8190adfdf9f8a6362221 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f15b7d00208190955a70e2c22d25a4 completed April 29, 2026, 1:14 a.m.
Created at: April 16, 2026, 8:48 p.m.